Genmab | GEN - Pre Tax Profit

Stock Price
1,657.00
Daily Change
-33.50 -1.98%
Monthly
-6.65%
Yearly
23.75%
Q2 Forecast
1,604.35

Genmab reported DKK55M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
Almirall EUR 30.32M 22M Dec/2025
Amarin USD -852K 7.26M Dec/2025
Amgen USD 1.51B 2.41B Dec/2025
argenx SE USD 403.29M 17.24M Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Demant DKK 1.64B 173M Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Fresenius Medical Care EUR 340M 168.46M Mar/2026
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
GN Store Nord DKK 450M 332M Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Insmed USD -162.1M 164.84M Mar/2026
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Lonza CHF 624M 197M Dec/2024
Merck EUR 401M 886.1M Dec/2025
Novartis USD 3.84B 802M Mar/2026
Regeneron Pharmaceuticals USD 1.04B 719.6M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025